PROSTATE cancerMAGNETIC resonance imagingMetastases were more common in the active monitoring group at 9.4% compared with the 4.7% and 5% who developed metastases in the prostatectomy and radiotherapy groups, respectively. Medical News in Brief Results from a trial involving 1643 ...
The results, released Saturday, are encouraging for men who want to avoid treatment-related sexual and incontinence problems, said Dr. Stacy Loeb, a prostate cancer specialist at NYU Langone Health who was not involved in the research. The study directly compared the three approaches — surgery t...
Prostate cancer is the most common cancer in men in the UK, accounting for almost a quarter of male cancers. Each year, nearly 32,000 men in the UK are diagnosed, and more than 10,000 die from the disease. Men have a one in 14 lifetime risk of developing prostate cancer. Cases are...
The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed, metastatic, castration-sensitive prostate cancer, concluded the STAMPEDE trial team funded by the Cancer Research UK. The findings were presented at the 2017 ASCO Annual Mee...
compared with LHRH agonists began recruitment in April 2006 in collaboration with the Clinical Trials Unit of the Medical Research Council supported by the National Cancer Research Network Prostate Cancer UK studies group and funded by Cancer Research UK. The prospects of a new estrogen dawn look ...
This study aimed to explore the opinions of healthcare professionals regarding the management of men with advanced prostate cancer with particular emphasis on treatment timing and sequencing; treatment adverse-effects and exercise a supportive therapy. Semi-structured interviews with a purposively selected...
prostatesexual relationship关键词:手册化治疗癌症慢性病状况亲密度Prostate cancer is the third most common cancer in the UK. Ten-year survival is high; consequently a service priority is addressing survivorship issues to support men living with the longer-term consequences of the disease and its ...
Prostate Cancer: Diagnosis and Treatment (Supplement) London: NICE.NICE. Prostate cancer: Diagnosis and treatment , (2008). Date accessed 28.06.12.NICE ( 2008 ) Prostate Cancer: Diagnosis and Treatment . ... T Cross,S Mcphail - National Collaborating Centre for Cancer (UK) 被引量: 97发表...
Professor Charles Swanton, Cancer Research UK’s chief clinician, said: “Adding radiotherapy to current treatment shows clear benefit for this subgroup of men with prostate cancer. “We now need to investigate whether this could also work for other types of cancer. If we can understand exactly ...
Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer SUBJECTS AND METHODS In the 'Prostate Testing for Cancer and Treatment' trial (ProtecT), men aged 50–69 years were recruited from nine cities in the ... AL Moore,P Dimitropoulou,A ...